Evercore ISI Group Maintains Outperform on CVS Health, Raises Price Target to $105

Benzinga Newsdesk www.benzinga.com Positive 82.3%

Neg 0% Neu 0% Pos 82.3%

Evercore ISI Group analyst Elizabeth Anderson maintains CVS Health (NYSE:CVS) with a Outperform and raises the price target from $100 to $105.